We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.3B
AUM Growth
-$128M
Cap. Flow
-$697M
Cap. Flow %
-6.16%
Top 10 Hldgs %
41.41%
Holding
1,243
New
52
Increased
320
Reduced
317
Closed
40

Sector Composition

Rank Sector Weight
1 Real Estate 72.31%
2 Technology 4.13%
3 Industrials 3.02%
4 Financials 2.93%
5 Healthcare 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HALO icon
1001
Halozyme
HALO
$9.72B
$16K ﹤0.01%
922
PTCT icon
1002
PTC Therapeutics
PTCT
$6.37B
$16K ﹤0.01%
365
ICPT
1003
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$16K ﹤0.01%
205
+16
+8% +$1.43K
ELP
1004
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$15K ﹤0.01%
3,000
MEDP icon
1005
Medpace
MEDP
$16.8B
$15K ﹤0.01%
227
XNCR icon
1006
Xencor
XNCR
$1.44B
$15K ﹤0.01%
358
MYOK
1007
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$15K ﹤0.01%
290
+34
+13% +$1.66K
INSM icon
1008
Insmed
INSM
$23.2B
$14K ﹤0.01%
549
+56
+11% +$1.56K
LGND icon
1009
Ligand Pharmaceuticals
LGND
$6.02B
$14K ﹤0.01%
197
-11
-5% -$810
LOGI icon
1010
Logitech
LOGI
$15.2B
$14K ﹤0.01%
+360
New +$14K
LTHM
1011
DELISTED
Livent Corporation
LTHM
$14K ﹤0.01%
+2,000
New +$18K
RETA
1012
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$14K ﹤0.01%
153
XLRN
1013
DELISTED
Acceleron Pharma
XLRN
$14K ﹤0.01%
329
GHDX
1014
DELISTED
Genomic Health, Inc.
GHDX
$14K ﹤0.01%
235
DNLI icon
1015
Denali Therapeutics
DNLI
$3.67B
$13K ﹤0.01%
604
MYGN icon
1016
Myriad Genetics
MYGN
$530M
$13K ﹤0.01%
466
AKCA
1017
DELISTED
Akcea Therapeutics Inc
AKCA
$13K ﹤0.01%
568
ZGNX
1018
DELISTED
Zogenix, Inc.
ZGNX
$13K ﹤0.01%
268
ALLK
1019
DELISTED
Allakos
ALLK
$12K ﹤0.01%
268
HLF icon
1020
PUT
Herbalife
HLF
$1.23B
$12K ﹤0.01%
500
RGNX icon
1021
Regenxbio
RGNX
$623M
$12K ﹤0.01%
232
TCDA
1022
DELISTED
Tricida, Inc. Common Stock
TCDA
$12K ﹤0.01%
309
+41
+15% +$1.44K
AXDX
1023
PUT
DELISTED
Accelerate Diagnostics
AXDX
$11K ﹤0.01%
100
-30
-23% -$5.87K
IRWD icon
1024
Ironwood Pharmaceuticals
IRWD
$611M
$11K ﹤0.01%
983
-191
-16% -$2.14K
PCRX icon
1025
Pacira BioSciences
PCRX
$1.02B
$11K ﹤0.01%
262

Similar funds

Daiwa Securities Group's Q2 2019 Portfolio in Review

As of Q2 2019, Daiwa Securities Group held 1,243 positions worth $11.3B, down 1.1% from $11.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group withdrew a net $697M in Q2 2019, closing 40 positions and reducing 317 holdings. Its most notable exit was L3Harris, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 74% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Coupa Software Incorporated worth $4.17M.

  • Daiwa Securities Group's largest Q2 2019 buy was Coupa Software Incorporated: 32,900 shares worth $4.17M.
  • Daiwa Securities Group added most to Host Hotels & Resorts in Q2 2019, an estimated $98.9M increase.
  • Daiwa Securities Group's biggest Q2 2019 reduction was Digital Realty Trust, cutting an estimated $144M.
  • Daiwa Securities Group fully exited L3Harris in Q2 2019, selling an estimated $3.77M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11.3B portfolio in Q2 2019.
  • Daiwa Securities Group opened 52 new positions and closed 40 in Q2 2019.
  • Daiwa Securities Group's portfolio value fell 1.1% quarter-over-quarter to $11.3B.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.